Farther Finance Advisors’s Krystal Biotech KRYS Stock Holding History

Farther Finance Advisors’s Portfolio KRYS Stock Details KRYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$30.9K	Buy	83 +28	+51%	+$8.37K	﹤0.01%	3637
2026 Q1	$14.2K	Buy	55 +16	+41%	+$4.26K	﹤0.01%	3890
2025 Q4	$9.62K	Buy	39 +6	+18%	+$1.26K	﹤0.01%	3948
2025 Q3	$5.83K	Buy	33 +9	+38%	+$1.35K	﹤0.01%	3693
2025 Q2	$3.3K	Buy	24 +1	+4%	+$147	﹤0.01%	3525
2025 Q1	$4.01K	Hold	23	–	–	﹤0.01%	3153
2024 Q4	$3.6K	Hold	23	–	–	﹤0.01%	2794
2024 Q3	$4.19K	Buy	23 +4	+21%	+$771	﹤0.01%	2716
2024 Q2	$3.46K	Hold	19	–	–	﹤0.01%	2557
2024 Q1	$3.35K	Hold	19	–	–	﹤0.01%	2261
2023 Q4	$2.36K	Buy	19 +16	+533%	+$1.77K	﹤0.01%	2365
2023 Q3	$348	Hold	3	–	–	﹤0.01%	2350
2023 Q2	$352	Buy	+3	New	+$306	﹤0.01%	2246

Other funds holding KRYS

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

MIF

Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

TAM

Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Farther Finance Advisors's KRYS Position: Q2 2026 in Review

Farther Finance Advisors increased its Krystal Biotech (KRYS) stake by 51% in Q2 2026, buying an estimated $8.37K and bringing the position to 83 shares worth $30.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3637.

Farther Finance Advisors first reported a position in KRYS in Q2 2023 and has held it in 13 quarters since. 68 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

Farther Finance Advisors held 83 shares of Krystal Biotech worth $30.9K as of Q2 2026.
Farther Finance Advisors bought 28 Krystal Biotech shares in Q2 2026, an estimated $8.37K.
Krystal Biotech made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #3637 holding.
Farther Finance Advisors first reported a position in Krystal Biotech in Q2 2023 and has held it in 13 quarters since.
68 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.